These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 12515562)
1. The pleiotropic effects of HMG-CoA reductase inhibitors: their role in osteoporosis and dementia. Waldman A; Kritharides L Drugs; 2003; 63(2):139-52. PubMed ID: 12515562 [TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture? Schlienger RG; Meier CR Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993 [TBL] [Abstract][Full Text] [Related]
3. Multitasking of the 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor: beyond cardiovascular diseases. Calabro P; Yeh ET Curr Atheroscler Rep; 2004 Jan; 6(1):36-41. PubMed ID: 14662106 [TBL] [Abstract][Full Text] [Related]
4. [The pleiotropic effects of statins]. Wolfovitz E Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. Miida T; Hirayama S; Nakamura Y J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707 [TBL] [Abstract][Full Text] [Related]
6. Potential use of HMG-CoA reductase inhibitors for osteoporosis. Cushenberry LM; de Bittner MR Ann Pharmacother; 2002 Apr; 36(4):671-8. PubMed ID: 11918519 [TBL] [Abstract][Full Text] [Related]
7. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management. Coons JC Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956 [TBL] [Abstract][Full Text] [Related]
8. Ongoing clinical trials of the pleiotropic effects of statins. Davignon J; Leiter LA Vasc Health Risk Manag; 2005; 1(1):29-40. PubMed ID: 17319096 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
11. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease. Höglund K; Blennow K CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225 [TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of statins and related pharmacological experimental approaches. Alegret M; Silvestre JS Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729 [TBL] [Abstract][Full Text] [Related]
13. [Statins as possible therapeutic tools for osteoporosis]. Takeuchi Y; Takeda S Clin Calcium; 2004 Feb; 14(2):302-7. PubMed ID: 15576989 [TBL] [Abstract][Full Text] [Related]
14. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects. Miida T; Takahashi A; Ikeuchi T Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151 [TBL] [Abstract][Full Text] [Related]
15. [Statins--"21st century aspirin"?]. Pawełczyk T; Kłoszewska I; Sobów T Pol Merkur Lekarski; 2005 Jul; 19(109):111-4. PubMed ID: 16194042 [TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
17. HMG CoA reductase inhibitors and the skeleton: a comprehensive review. Bauer DC Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772 [TBL] [Abstract][Full Text] [Related]
18. Non-lipid effects of statins: emerging new indications. Yildirir A; Müderrisoglu H Curr Vasc Pharmacol; 2004 Oct; 2(4):309-18. PubMed ID: 15320810 [TBL] [Abstract][Full Text] [Related]
19. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Wang CY; Liu PY; Liao JK Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482 [TBL] [Abstract][Full Text] [Related]